insights_auto
Miks on SDZNY tõusnud? 2,14%?
Uurige põhjalikumaltchevron_right
SDZNY:OTCMKTS
SANDOZ GROUP ADR
92,98 $
arrow_upward
+2,14%(+1,94) 1 p
16. okt, 16:00:00 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SDZNY põhistatistika genereerimine…
Ava
92,15 $
Kõrge
93,52 $
Madal
92,15 $
Turu kapit.
33,87 mld
Keskm. maht
27,16 tuh
Maht
24,96 tuh
52 näd kõrgeim
94,15 $
52 näd madalaim
60,40 $
Käibivad aktsiad
440,00 mln
Töötajate arv
20 tuh
Ava
92,15 $
Kõrge
93,52 $
Madal
92,15 $
Turu kapit.
33,87 mld
Keskm. maht
27,16 tuh
Maht
24,96 tuh
52 näd kõrgeim
94,15 $
52 näd madalaim
60,40 $
Käibivad aktsiad
440,00 mln
Töötajate arv
20 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
ad-hoc-news.de
·
10 tunni eest
Sandoz stock: October 28 results are due for Sandoz stock
ad-hoc-news.de
·
19 tunni eest
Sandoz stock pre-market at EUR 81.94
ad-hoc-news.de
·
1 päeva eest
Barclays keeps CHF 93.00 target for Sandoz stock
Profiil
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Teave üksuse SANDOZ GROUP ADR kohta